Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.
3.

Molecular genetics of bipolar disorder and depression.

Kato T.

Psychiatry Clin Neurosci. 2007 Feb;61(1):3-19. Review.

4.

[Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].

Pan YX, Wu Y, Niu ZP, Jiang YW.

Beijing Da Xue Xue Bao. 2009 Oct 18;41(5):608-10. Review. Chinese.

5.

Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios.

Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, Valle D, Pulver AE.

Am J Hum Genet. 2005 Dec;77(6):918-36.

6.

The genetics of schizophrenia and bipolar disorder: dissecting psychosis.

Craddock N, O'Donovan MC, Owen MJ.

J Med Genet. 2005 Mar;42(3):193-204. Review.

7.

Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice.

Lin Y, Pang X, Huang G, Jamison S, Fang J, Harding HP, Ron D, Lin W.

J Neurosci. 2014 Sep 3;34(36):12182-91. doi: 10.1523/JNEUROSCI.1373-14.2014.

9.

Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.

van der Knaap MS, Leegwater PA, Könst AA, Visser A, Naidu S, Oudejans CB, Schutgens RB, Pronk JC.

Ann Neurol. 2002 Feb;51(2):264-70.

PMID:
11835386
11.

Psychosis and relapse in bipolar disorder are related to GRM3, DAOA, and GRIN2B genotype.

Dalvie S, Horn N, Nossek C, van der Merwe L, Stein DJ, Ramesar R.

Afr J Psychiatry (Johannesbg). 2010 Sep;13(4):297-301.

PMID:
20957330
15.

Genetics of bipolar disorder.

Kato T, Kuratomi G, Kato N.

Drugs Today (Barc). 2005 May;41(5):335-44. Review.

PMID:
16082431
16.

Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction.

Vilella E, Costas J, Sanjuan J, Guitart M, De Diego Y, Carracedo A, Martorell L, Valero J, Labad A, De Frutos R, Nájera C, Moltó MD, Toirac I, Guillamat R, Brunet A, Vallès V, Pérez L, Leon M, de Fonseca FR, Phillips C, Torres M.

J Psychiatr Res. 2008 Mar;42(4):278-88.

PMID:
17408693
17.

The large spectrum of eIF2B-related diseases.

Fogli A, Boespflug-Tanguy O.

Biochem Soc Trans. 2006 Feb;34(Pt 1):22-9. Review.

PMID:
16246171
18.

Leukoencephalopathy with vanishing white matter: a review.

Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS.

J Neuropathol Exp Neurol. 2010 Oct;69(10):987-96. doi: 10.1097/NEN.0b013e3181f2eafa. Review.

19.

eIF2 independently binds two distinct eIF2B subcomplexes that catalyze and regulate guanine-nucleotide exchange.

Pavitt GD, Ramaiah KV, Kimball SR, Hinnebusch AG.

Genes Dev. 1998 Feb 15;12(4):514-26.

20.

N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels.

Martucci L, Wong AH, De Luca V, Likhodi O, Wong GW, King N, Kennedy JL.

Schizophr Res. 2006 Jun;84(2-3):214-21.

PMID:
16549338
Items per page

Supplemental Content

Support Center